Berlin School of Integrative Oncology (BSIO)
Under the direction of Professor Clemens Schmitt, Director of the Molekulares Krebsforschungszentrum and Leading Consultant of the Haematology and Oncology Department at the Charité, the Charité is submitting a joint proposal with Humboldt-Universität, Freie Universität, and the non-university partner institutes Max Planck Institute for Molecular Genetics, Max Planck Institute of Molecular Plant Physiology and Max Delbrück Center for Molecular Medicine, for the establishment of a Graduate School to be called the Berlin School of Integrative Oncology (BSIO).
The 25 scientists and scholars in the BSIO planning group, who come from the fields of haematology, oncology, genetics, biochemistry, surgery, radiology, computer science, the social sciences and the humanities, are working on a strongly interdisciplinary concept to provide young doctors and future molecular oncologists with the theoretical background and practical experience they need to develop new methods for the diagnosis and treatment of cancer.
The close communication between life sciences research and clinical application has the advantage of accelerating the development of new forms of treatment for patients and ensuring that experimental research in the laboratory gives top priority to the most urgent problems in the clinical treatment of cancer.
This comprehensive concept for training outstanding young scientists from the very outset of their career will provide the foundation for interdisciplinary research that is equipped to develop effective strategies to tackling the challenge presented by cancer as fast as possible.